Flash FinanceUS
Market closed S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Globus Medical (GMED)

Globus Medical Reports Q3 2026 Results and $500M Share Repurchase Program Increase

Mixed Impact 4 of 5 guidance

Globus Medical reported third quarter 2026 worldwide net sales of $763.7 million, representing a 0.7% decrease compared to the same period in 2025, alongside GAAP net income of $141.2 million. The company updated its full-year 2026 revenue guidance to $3.09 billion and announced a $500 million increase to its share repurchase program.

Key points

  • Worldwide net sales were $763.7 million for the third quarter ended September 30, 2026, down 0.7% year-over-year.
  • GAAP diluted earnings per share increased 18.2% to $1.04 for the quarter.
  • The Board authorized an additional $500.0 million share repurchase program increase on November 2, 2026.
  • Full-year 2026 revenue guidance was updated to $3.09 billion.

The filing

CompanyGlobus Medical (GMED)
Form8-K, current report
Filed with the SECNov 5, 2026, 4:09 PM ET
Accession number0001628280-26-071042

Items reported: 2.02 Results of Operations8.01 Other Events

Read the filing on SEC.gov ↗

Written by AI on Nov 6, 2026, 11:16 AM ET, from this filing only.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.